Reading Time: 2 minutes## Introduction Neuromuscular disorders (NMDs) represent a spectrum of debilitating conditions characterized by progressive muscle weakness, fatigue, and impaired motor function, disproportionately affecting American males due to genetic predispositions and occupational hazards. Conditions such as amyotrophic lateral sclerosis (ALS), myasthenia gravis (MG), and spinal muscular atrophy (SMA) disrupt the neuromuscular junction (NMJ)—the critical synapse between motor neurons and skeletal muscle fibers. Sermorelin, a synthetic analog of growth hormone-releasing hormone (GHRH), has emerged as a promising therapeutic agent. By stimulating endogenous growth hormone (GH) and insulin-like growth factor-1 (IGF-1) secretion, sermorelin may enhance NMJ stability, synaptic transmission, and muscle innervation. This … Continue reading →